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Abstract
Background: Lipopolysaccharide (LPS) treatment of animals down-regulates the expression of
hepatic genes involved in a broad variety of physiological processes, collectively known as the
negative hepatic acute phase response (APR). Retinoid X receptor α (RXRα), the most highly
expressed RXR isoform in liver, plays a central role in regulating bile acid, cholesterol, fatty acid,
steroid and xenobiotic metabolism and homeostasis. Many of the genes regulated by RXRα are
repressed during the negative hepatic APR, although the underlying mechanism is not known. We
hypothesized that inflammation-induced alteration of the subcellular location of RXRα was a
common mechanism underlying the negative hepatic APR.
Results: Nuclear RXRα protein levels were significantly reduced (~50%) within 1–2 hours after
low-dose LPS treatment and remained so for at least 16 hours. RXRα was never detected in
cytosolic extracts from saline-treated mice, yet was rapidly and profoundly detectable in the
cytosol from 1 hour, to at least 4 hours, after LPS administration. These effects were specific, since
the subcellular localization of the RXRα partner, the retinoic acid receptor (RARα), was unaffected
by LPS. A potential cell-signaling modulator of RXRα activity, c-Jun-N-terminal kinase (JNK) was
maximally activated at 1–2 hours, coincident with maximal levels of cytoplasmic RXRα. RNA levels
of RXRα were unchanged, while expression of 6 sentinel hepatic genes regulated by RXRα were
all markedly repressed after LPS treatment. This is likely due to reduced nuclear binding activities
of regulatory RXRα-containing heterodimer pairs.
Conclusion: The subcellular localization of native RXRα rapidly changes in response to LPS
administration, correlating with induction of cell signaling pathways. This provides a novel and
broad-ranging molecular mechanism for the suppression of RXRα-regulated genes in inflammation.
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Background
LPS, a major constituent of the outer membrane of gram-
negative bacteria, potently stimulates host innate immune
response [1]. LPS-induced activation of monocytes/mac-
rophages leads to the release of proinflammatory
cytokines such as interleukin-1β (IL-1β), interleukin-6
(IL-6), and tumor necrosis factor-α (TNFα) in addition to
other mediators such as cysteinyl leukotrienes [2]. LPS
and LPS-induced cytokines have been implicated in the
pathogenesis and progression of a variety of liver diseases,
including cholestasis, as well as being principal mediators
of the negative hepatic APR [3]. The cholestatic effect of
LPS is primarily due to cytokine-mediated inhibition of
the function and expression of hepatic genes encoding
critical proteins involved in bile formation and transport
(reviewed in [4]). These hepatocellular transporters
include the basolateral sodium/taurocholate cotrans-
porter (Ntcp/Slc10a1) and organic anion transporting pro-
teins (Oatp1/Slc21a1), as well as the canalicular
multispecific organic anion exporter (Mrp2/Abcc2) and
the bile salt export protein (Bsep/Abcb11). Transcriptional
down-regulation of the principal hepatic bile acid
importer, Ntcp contributes to the reduction in bile acid
uptake by hepatocytes in inflammation, whereas reduced
Mrp2 expression leads to impaired excretion of conju-
gated bilirubin, glutathione and other organic anions into
bile [5,6].
Recent reports have provided insights into the link
between inflammation-mediated cell signaling and regu-
lation of bile acid homeostasis in the liver. Geier et al.
showed that LPS-mediated suppression of Ntcp RNA was
almost completely blocked by pre-treatment with anti-IL-
1β specific antibodies, indicating that the cholestatic
effects of LPS on the expression of this gene may be prima-
rily mediated by the cell signaling pathways initiated by
this one cytokine [7]. We have shown that IL-1β treatment
of HepG2 cells, or primary rat hepatocytes, leads to JNK-
dependent repression of nuclear binding activity of the
Ntcp transactivator, RXRα:RARα, with consequent down-
regulation of Ntcp  promoter activity [8]. Finally, LPS,
cytokines, and activated JNK have been linked to reduced
expression of the rate-limiting enzyme in the bile acid bio-
synthetic pathway, cholesterol 7α-hydroxylase (CYP7A1),
thus linking inflammatory signaling in the liver to the
known and coordinated suppression of both bile acid
import and synthesis [9-11]. How activated JNK leads to
reduced RXRα function is not known, but is likely to
involve direct phosphorylation of RXRα [8].
Phosphorylation of nuclear receptors (NRs) is a rapid and
potentially powerful means of regulating NR activity, that,
depending upon the NR, can affect transcriptional activ-
ity, protein stability, sub-cellular localization, protein-
protein interactions or DNA binding activity [12,13].
Phosphorylation of transfected RXRα was reported to alter
its transactivation properties in vitro, however, a definite
functional role for native RXRα phosphorylation remains
controversial. Both enhanced and reduced proteasome-
mediated RXRα degradation have been associated with
RXRα phosphorylation [14,15]. Hyperphosphorylation
of RXRα by JNK was reported by Adam-Stitah et al [16]
and the phosphorylation sites were mapped to several res-
idues (serines 61 and 75 and threonine 87) in the N-ter-
minal region and serine 265 in the ligand binding domain
of mouse RXRα. However, JNK-mediated hyperphospho-
rylation of RXRα did not affect the transactivation proper-
ties of transfected RXRα homodimers or RXRα:RARα
heterodimers in cultured cells [16]. In contrast, we and
others have demonstrated that phosphorylation of RXRα
by JNK signaling pathways is associated with reduced
RXRα-dependent promoter activity [8,17]. Clearly, the
consequences of RXRα phosphorylation are complex and
poorly understood.
NR ligands and extracellular signal-mediated pathways
can alter subcellular NR localization, some of which
involves phosphorylation-dependent mechanisms
[12,13,18-20]. The xenobiotic receptors, CAR (NR1I3)
[19] and PXR (NR1I2) [20] are localized in the cytoplasm
of mouse hepatocytes and translocated into the nucleus
after administration of their respective ligands. GR and
VDR are well-known to undergo ligand-dependent
nuclear import in transfected cells [12,13,18,21]. In con-
trast to the well-described events leading to NR nuclear
import, little is known about NR nuclear export, including
RXRα. Perhaps the best understood example of cell sign-
aling targeting of NR nuclear export is JNK-mediated
phosphorylation of GR, as a means of terminating GR-
mediated transcription [18]. Such a mechanism for RXRα
has never been shown, although a reduction in nuclear
RXRα protein levels has been demonstrated in an animal
model of obstructive cholestasis induced by bile duct liga-
tion, raising the possibility of nuclear export [22].
In these studies, we sought to determine whether altera-
tions in RXRα-dependent hepatic gene expression seen in
inflammation may be related to nucleo-cytoplasmic re-
distribution of RXRα. LPS treatment resulted in the activa-
tion of hepatic JNK coinciding with marked reduction in
nuclear RXRα levels, and the rapid appearance of RXRα in
the cytosol. RNA levels of RXRα  and six of its het-
erodimeric partners highly expressed in liver were ana-
lyzed after LPS treatment: RXRα, RARα, FXR (farnesoid X
receptor) and PPARα (peroxisome proliferator-activated
receptor) RNA levels were stable, whereas CAR (constitu-
tive androstane receptor) and PXR (pregnane X receptor)
RNA levels were markedly suppressed and LXR (liver X
receptor) RNA was elevated. Hepatic RNA levels of multi-
ple RXRα target genes whose expression depends uponNuclear Receptor 2004, 2:4 http://www.nuclear-receptor.com/content/2/1/4
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adequate nuclear levels of RXRα were significantly
reduced by LPS. This is likely to be a consequence of
reduced nuclear binding activity of RXRα heterodimer
pairs. Notably, the reduction in RXRα nuclear protein lev-
els (~50%) quantitatively correlated with the reduction in
RNA levels of RXRα target genes. Taken together, these
studies indicate that post-translational modification and
cellular re-distribution of RXRα coinciding with induction
of cell signaling is a novel, broad-ranging, and rapid
mechanism contributing to the negative hepatic APR phe-
notype in the inflamed liver.
Results
LPS activates hepatic JNK
In order to determine the in vivo role for LPS-induced acti-
vation of hepatic JNK, we first established a time course
for JNK activation, by measuring phospho-JNK and phos-
pho-c-Jun levels. Liver whole cell extracts were prepared at
various time points from 1–16 hours after injection with
either LPS (2 µg/g bw) or vehicle (0.9% saline) (Fig. 1A).
Phosphorylated JNK levels were maximal at 1–2 hours,
and significantly higher than saline-injected animals at all
time points studied. Total JNK levels did not vary between
vehicle and LPS-treated samples. c-Jun is a direct substrate
for phospho-JNK, and phospho-c-Jun levels are a well-
described indicator of JNK activity [23]. LPS treatment led
to maximal c-Jun phosphorylation at 1 to 2 hours, with a
slight reduction at 4 and 6 hours, and was undetectable by
16 hours. Thus, in an animal model, LPS administration
activates JNK signaling in the liver as early as 1 hour, with
evidence for prolonged JNK activity lasting at least 6
hours.
LPS treatment leads to the rapid reduction of nuclear 
RXRα protein levels concomitant with the appearance of 
RXRα in the cytoplasm
Treatment of HepG2 cells or primary rat hepatocytes with
IL-1β leads to JNK-dependent repression of RXRα :RARα
nuclear binding activity, with the consequent down-regu-
lation of target gene expression [8]. However, whether
such changes are observed in RXRα activity after LPS chal-
lenge in an animal model is unknown. As early as one
hour after LPS treatment, the maximal point of JNK acti-
vation, nuclear RXRα levels were significantly reduced
compared to control, and remained so for at least 16
hours after LPS treatment (Fig. 1B). RXRα was not present
in the cytoplasmic fraction at any time point after saline
treatment, yet was robustly evident within one to two
hours after LPS treatment, and decreased thereafter. Inter-
estingly, immunoblot analysis of nuclear RXRα revealed a
slower migrating species after LPS treatment (most evi-
dent in the 1 hour LPS sample), suggestive of LPS-induced
post-translational modification. Notably, hepatic RARα
levels in both nuclear and cytoplasmic compartments
were unchanged by LPS.
To confirm the intracellular localization of RXRα in liver,
immunofluorescence staining was carried out in forma-
lin-fixed liver tissues prepared from mice 1 h after saline
or LPS injection (Fig. 1C). In LPS-treated mouse livers,
RXRα was clearly observed in both the nucleus and cyto-
plasm of hepatocytes, whereas it remained exclusively
nuclear in saline-treated controls. Thus, there is a rapid,
dramatic, and specific subcellular re-distribution of
hepatic RXRα in response to LPS-administration, coincid-
ing with induction of cell signaling.
Effect of LPS on steady-state mRNA levels of RXRα and its 
partners in the liver
One possible explanation for reduced nuclear RXRα levels
could be suppression of hepatic RXRα RNA expression, as
seen in response to higher doses of LPS [24]. We investi-
gated whether low dose LPS administration had an effect
on the RNA levels of RXRα, six of its heterodimeric part-
ners and SHP–all known to be involved in hepatic gene
expression [25] (Fig. 2A). At 16 h after LPS administra-
tion, RNA levels for RXRα, RAR, FXR and PPARα were
unchanged, whereas PXR  and  CAR  RNA levels were
reduced and LXRα RNA levels were increased (Fig. 2A).
LPS-mediated down-regulation of PXR and CAR RNA lev-
els in mice have been reported by Beigneux et al[26], how-
ever our results do not support the reduction in RNA
levels of RXRα, FXR and LXR and PPARα seen by others,
perhaps due to differences in the experimental model, LPS
dose or mouse strain [24,27].
Hepatocyte-selective RXRα-null mice have impaired met-
abolic function, with reductions in CAR, FXR, LXRα,
PPARα, and PXR target gene expression [28]. As examples
of genes regulated by RXRα and its partners, we studied
RNA expression of six sentinel hepatic genes regulated by
various RXRα heterodimer pairs: Ntcp  (RARα),  Bsep
(FXR),  Mrp2  (CAR, FXR, PXR), Cyp3A11  (CAR, PXR),
Abcg5 (LXRα) and Lfabp (PPARα) (Fig. 2B). RNA levels of
all of these hepatic RXRα-regulated genes were signifi-
cantly reduced by LPS treatment. Ntcp, Bsep and Abcg5
RNA levels decreased by 50–60%, Cyp3A11 RNA by 80%,
while  Lfabp  and  Mrp2  expression were each reduced
approximately 60–70% after LPS treatment. The compar-
atively greater reduction in Cyp3A11 gene expression can
be attributed to the combined effects of diminished PXR
and CAR RNA expression along with reduced nuclear
RXRα protein levels; both PXR & CAR activate Cyp3A11
gene expression (reviewed in [29]).
The orphan nuclear receptor SHP (small heterodimer pro-
tein, NR0B2) is known to repress the activities of RXRα
and other NRs [11,29]. One possibility is that LPS-medi-
ated suppression of hepatic genes could be mediated by
the activation of the repressor, SHP [9]. However, this is
unlikely, since LPS treatment dramatically reduced SHPNuclear Receptor 2004, 2:4 http://www.nuclear-receptor.com/content/2/1/4
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RNA levels (Fig. 2A). Taken together, these studies indi-
cate that the effect of LPS on hepatic RXRα-dependent
gene expression is not due to reduced RXRα RNA levels or
increased SHP–rather it appears to be a consequence of
post-translational modification and rapid LPS-induced
subcellular re-distribution of RXRα protein. This is in
agreement that SHP-1 is a FXR/RAR target gene [11].
Effect of LPS on DNA binding activity of Type II nuclear 
receptor pairs in liver
In order to determine if reduced nuclear RXRα protein lev-
els leads to impaired DNA binding activity of RXRα and
its partners, electrophoretic mobility shift analyses were
performed. Nuclear extracts were prepared from livers of
saline or LPS-treated mice and incubated with oligonucle-
otides containing canonical DNA elements scanning Type
II NR binding sites–direct repeats of the hexad AGGTCA,
separated by 1 to 5 nucleotides (DR1-5), or an inverted
LPS activates JNK and leads to rapid nuclear export of RXRα Figure 1
LPS activates JNK and leads to rapid nuclear export of RXRα. C57BL/6 male mice were injected IP with 0.9% saline 
(Sal) or 2 µg/g bw of Salmonella LPS. Livers were isolated at the indicated time-points and whole cell extracts were prepared. 
A. Phosphorylation of c-JUN (P-cJUN) and JNK (P-JNK) was determined by immunoblotting cell lysates with phospho-c-JUN 
and phospho-JNK antibodies respectively. Total JNK levels in the liver tissue (JNK) are shown in the lower panels. This data is 
representative of three animals per treatment group. B. Nuclear (Nuc) and cytosolic (Cyt) extracts were analyzed by immuno-
blotting with antibodies to RXRα and RARα to determine subcellular localization of RXRα. The extracts from 4 animals were 
combined to account for inter-animal variability. Note the high molecular weight smear in LPS-treated extractions (most evi-
dent at 1 h). Data quantified and normalized to saline-injected samples (set at 1.0). C. Immunofluorescent analysis of formalin-
fixed mouse liver tissues after 1 h of saline or LPS treatment. The blue color indicates DAPI staining of the nuclei, the green 
color indicates RXRα detected with FITC-labeled secondary antibody, DAPI/FITC are the merged images. The saline and LPS-
treated samples are represented in the left and right panels, respectively.
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repeat separated by 1 nucleotide (IR1) [30,31]. As Type II
NRs, RXRα partners with either RARα, PPARα, PXR, CAR,
LXR or FXR to bind to one or more of these sites (reviewed
in [25]). At 16 h after LPS treatment, binding to all 6
Effects of LPS on RNA levels of NRs and RXRα target genes Figure 2
Effects of LPS on RNA levels of NRs and RXRα target genes. C57BL/6 mice were injected with 0.9% saline (white bars) 
or 2 µg/g bw of Salmonella LPS (black bars) for 16 hours (n = 6 per group). RNA was prepared from the livers and analyzed for 
A. NRs and B. RXRα target genes by real-time PCR. All data were presented as mean ± SD and standardized for GAPDH 
RNA levels. Expression in the saline-treated control animals was set to 1. The asterisks indicate significant difference (p < 0.05). 
See supplemental information for primers and probes.
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RXRα-containing canonical sequences was significantly
reduced in hepatic nuclear extracts from LPS-treated ani-
mals (~45–70% reduction) (Fig. 3), consistent with a
diminished nuclear RXRα. Since the expression of PXR
and CAR was reduced upon LPS administration (Fig. 2A),
there was a more dramatic decrease in binding to their rec-
ognition elements, DR3 and DR4 (~70% reduction).
Binding to the consensus AP1 DNA sequence was
increased (~70%) upon administration of LPS; this serves
as a positive control for JNK-mediated activation of
hepatic inflammation as well as an indication of specifi-
city of suppression of RXRα-heterodimer pair DNA bind-
ing (Fig. 3).
Discussion
The negative hepatic APR is characterized by suppression
of hepatic gene expression in response to inflammation
and is well-modeled by LPS administration [32,33]. We
hypothesized that reduced nuclear levels of RXRα after
LPS administration would be manifested by broad altera-
tions in RXRα-dependent gene expression across diverse
physiological processes [28]. Our results demonstrate that
LPS signaling induces rapid and profound reduction of
hepatic nuclear RXRα protein levels, concomitant with
appearance of RXRα in the cytoplasm, leading to subse-
quent reduction in the expression of RXRα-dependent
hepatic genes.
Recent studies have led to a broader understanding of the
molecular basis for the role of LPS in intracellular signal-
ing and hepatic function [24,26,34]. Activation of mono-
cytes/macrophages by LPS leads to the secretion of a
number of proinflammatory cytokines such as TNFα, IL-
1β, and IL-6 [2]. LPS-induced activation of Kupffer cells,
the resident hepatic macrophages, triggers several crucial
intracellular signaling pathways in hepatocytes, including
stress-activated mitogen-activated protein kinases, extra-
cellular signal-regulated kinase (ERK), JNK and p38
mitogen-activated protein kinase (p38 MAPK) [35].
Stress-activated protein kinases, mitogen-activated pro-
tein kinase kinase-4 (MKK4/SEK1) and its downstream
mediator JNK was shown to directly phosphorylate
RXRα[8,17]. Previous studies by our group[8] demon-
strated that inhibition of the JNK signaling pathway
LPS reduces binding activities of RXRα-containing heterodimer pairs to canonical DNA elements Figure 3
LPS reduces binding activities of RXRα-containing heterodimer pairs to canonical DNA elements. Electro-
phoretic mobility shift assay analysis of hepatic nuclear extracts prepared from C57BL/6 mice injected with control saline or 2 
µg/g bw LPS for 16 h. Radiolabeled double-stranded DR1, DR2, DR3, DR4 and DR5 elements or a consensus AP1 element 
were employed (see Materials and Methods). The samples were electrophoresed through a 6% non-denaturing polyacrylamide 
gel, dried and analyzed by autoradiography.
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completely blocked IL-1β-mediated suppression of RXRα-
dependent Ntcp gene expression, thus implicating JNK to
be a central player in inflammation-induced cholestasis.
Most evident in the 1 hour sample are high molecular
weight forms of RXRα, consistent with covalent post-
translational modification (Fig. 1B), although the actual
nature of this high molecular weight species is currently
unknown and under investigation. One plausible inter-
pretation of these data is that LPS-induced activation of
JNK leading to phosphorylation and likely further modi-
fication of RXRα, triggering its transport from nucleus to
cytoplasm, where it may be targeted for degradation.
Phosphorylation has been shown to be involved in the
degradation of RXRα :RARα heterodimers by proteas-
omes, thus providing a mechanism for JNK-mediated
inhibition of RXRα-dependent target gene transactiva-
tion[14,15] RNA levels of RXRα were not affected by LPS,
further supporting nuclear export of RXRα as a primary
mechanism of suppression of hepatic genes during nega-
tive hepatic APR.
The interrelationship and roles played by JNK and phos-
pho-RXRα are neither readily nor definitively explored in
an in vivo model, especially using such a broadly-acting
inflammatory agent like LPS. Hepatocytes and liver-
derived HepG2 cells in culture respond to LPS-induced
cytokines like TNFα and IL-1β by suppressing the expres-
sion of negative hepatic APR genes [8,24,26,36]. Recent
work in our laboratory indicates that treatment of HepG2
cells with IL-1β leads to RXRα nuclear export, dependent
upon JNK-mediated phosphorylation of select residues in
RXRα (Zimmerman et al., manuscript in preparation). In
transfected cells, nerve growth factor (NGF)-induced
phosphorylation of the orphan nuclear receptor NGFI-B
(Nur77) resulted in the translocation of RXR-NGFI-B
complex out of the nucleus, indicating that distribution of
RXR in these cells was regulated by NGFI-B [37]. The data
presented here are the first to indicate that inflammation-
mediated cell signaling leads to rapid subcellular redistri-
bution of native RXRα, changing the previous impression
of RXRα as a stable nuclear resident [38]. Finally, these
findings indicate significant cross-talk between JNK-sign-
aling and NR-mediated gene expression.
Conclusions
Overall, we conclude that RXRα is rapidly exported out of
the nucleus in response to LPS. RXRα, as an obligate het-
erodimer with other class II NRs, regulates the expression
of a broad array of genes involved in critical metabolic
pathways in the liver, many of which are impaired during
the negative hepatic APR. This helps explain how inflam-
mation-induced signaling can lead to rapid, diverse and
multiple alterations in hepatic gene expression, which has
implications for future therapeutic targets of both acute
and chronic liver diseases.
Materials and methods
Materials
LPS (Salmonella typhimurium) was purchased from Sigma
Chemical Co. (St. Louis, MO) and freshly diluted to the
desired concentration in pyrogen-free 0.9% saline before
injection. Anti-JNK (#9252), phospho-JNK (#9251) and
phospho-cJUN antibodies (Ser 63) (#9261) (Cell Signal-
ing, Beverly, MA); anti-RXRα (D-20) (#sc-553) and anti-
RARα antibodies (#sc-551) (Santa Cruz Biotechnology,
Santa Cruz, CA) were used according to manufacturer's
instructions. [γ-32P]ATP was obtained from PerkinElmer
Life Sciences (Boston, MA). Oligonucleotides were
obtained from Sigma Genosys and Synthegen, Houston,
TX. All reagents for real-time PCR were purchased from
Applied Biosystems (Foster City, CA).
Animals
Adult male (8–10 weeks) C57BL/6 mice (20–25 g) were
purchased from Charles River Laboratories, (Wilmington,
MA). The animals were maintained in a temperature- and
humidity-controlled environment and were provided
with water and rodent chow ad lib. Mice were given intra-
peritoneal injection with 2 µg/g body wt LPS (Salmonella
typhimurium; Sigma Chemical Co., St. Louis, MO) in
saline or saline alone. LPS in this dose range has been
shown previously to induce cholestasis, maximally
inhibit bile acid uptake, and significantly reduce Ntcp
mRNA from 12 to 16 hours after injection, while not
inducing hepatic damage [6,39]. Livers were removed at
the time indicated in the figure legends (1 to 16 hours)
after treatment. All animal protocols were approved by
the Baylor College of Medicine Institutional Animal Care
and Use Committee. Experiments were performed in trip-
licate and repeated three to four times.
Preparation and analysis of nuclear and cytoplasmic and 
whole cell extracts
Nuclear and cytoplasmic extracts were prepared according
to Itoh et al[18] Whole cell extracts were prepared accord-
ing to Li et al [8]. Protein concentration was determined
by BCA assay according to the manufacturer's protocol
(Pierce, Rockford, IL). These fractions were analyzed by
immunoblotting. Signals were developed by a standard
enhanced chemiluminescence method following the
manufacturer's protocol (Perkin Elmer Life Sciences, Bos-
ton, MA) and quantified by a densitometer using Image-
Quant software.
Immunofluorescent analysis
Livers were isolated from saline and LPS injected mice
after 1 hour of treatment, fixed in 10% buffered neutral
formalin overnight at 4°C and then stored in 70% etha-
nol. Fluorescent detection was performed by using anti-
RXRα (D-20) antibody and fluorescein isothiocyanate
(FITC)-labeled secondary antibody and nuclei was stainedNuclear Receptor 2004, 2:4 http://www.nuclear-receptor.com/content/2/1/4
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with 4'-6-diamidino-2-phenylindole (DAPI). Visualiza-
tion was performed with a Deltavision Spectris Deconvo-
lution Microscope System (Applied Precision, Inc.).
Electrophoretic gel mobility shift assays
Nuclear extracts were prepared according to Timchenko et
al.[40] with some modifications. Double-stranded oligo-
nucleotide probes were end-labeled and purified accord-
ing to standard procedures [41]. 10 µg of nuclear extracts
were incubated on ice for 30 min with 32P end-labeled oli-
gonucleotide as described previously [41]. The oligonu-
cleotide sequences are provided in Table 1. After binding,
the samples were electrophoresed through a non-denatur-
ing 6% polyacrylamide gel, dried and exposed to x-ray
film. In addition, gels were exposed to a PhosphorImager
screen and quantified using a PhosphorImager and
ImageQuant software.
Real time quantitative PCR analysis
Total RNA was isolated from mouse liver tissues using the
RNaesy kit from Qiagen. cDNA was synthesized from 7.5
µg of total RNA using the ProSTAR™ First-Strand RT-PCR
Kit (Stratagene, La Jolla, CA). Real time quantitative PCR
(RTQ-PCR) was performed using an ABI PRISM 7700
Sequence Detection System instrument and software
(Applied Biosystems, Inc., Foster City, CA). Briefly, each
amplification reaction (50 µl) contained 40–200 ng of
cDNA, 300 nM of forward primer, 300 nM of reverse
primer, 200 nM of fluorogenic probe and 25 µl of Taq-
Man®  Universal PCR master mix. PCR thermocycling
parameters were 50°C for 2 min, 95°C for 10 min and 40
cycles of 95°C for 15 s, and 60°C for 1 min. Quantitative
expression values were extrapolated from standard curves
and were normalized to GAPDH. The sequences of the
primers and probes were obtained from the literature [42]
or purchased from Applied Biosystems, and are listed in
Table 2.
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GAPDH, glyceraldehyde-3-phosphate dehydrogenase;
APR, acute phase response; DR, Direct Repeat; IR, Inverted
Repeat; FITC, fluorescein isothiocyanate; DAPI, 4'-6-dia-
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